https://www.selleckchem.com/pr....oducts/gusacitinib.h
I. Single-isocenter dynamic conformal arc (SIDCA) therapy is atechnically efficient way of delivering stereotactic radiosurgery (SRS) to multiple metastases simultaneously. This study reports on the safety and feasibility of linear accelerator (LINAC) based SRS with SIDCA for patients with multiple brain metastases. All patients who received SRS with this technique between November 2017 and June 2019 within aprospective registry trial were included. The patients were irradiated with adedicated planning tool for multiple brain metast
Respect!
Kommentar
Delen
